UnitedHealth Group Incorporated (UNH)
549.62 USD -29.35 (-5.07%) Volume: 12.85M
UnitedHealth Group Incorporated’s stock price stands at 549.62 USD, experiencing a downturn this trading session with a -5.07% change, amidst a trading volume of 12.85M. Despite the recent dip, UNH’s year-to-date performance remains positive, showcasing a 4.40% increase, underlining the stock’s resilience in the market.
Latest developments on UnitedHealth Group Incorporated
UnitedHealth Group stock prices experienced significant movements today following the tragic shooting of UnitedHealthcare CEO Brian Thompson in New York City. The company’s shares plummeted as news of the CEO’s murder spread, marking the worst week for UnitedHealth since the Covid shutdown. The shooting prompted a manhunt for the suspect who allegedly left the city by bus, leaving employees and investors shocked and concerned. The incident has shed light on the complex challenges faced by companies in protecting top executives and has sparked a flurry of social media responses expressing frustration with the health insurance industry. As the investigation continues and the motive remains unknown, UnitedHealth Group issued a statement expressing their grief over the loss of Brian Thompson.
UnitedHealth Group Incorporated on Smartkarma
Analyst Joe Jasper from Smartkarma has upgraded his coverage on UnitedHealth Group to Market Weight. In his research report titled “Upgrading Health Care to Market Weight; Risk-Off Signals Suggest SPX and QQQ Pullback to Continue,” Jasper highlights new risk-off signals indicating a potential pullback in the S&P 500 and QQQ. He is looking for pullbacks to 5100-5191 on the S&P 500 and $443-$449 on the QQQ. Jasper notes that breadth continues to improve and small-cap stocks like Russell 2000 and Dow remain bullish, while the S&P 500 and QQQ are going through a consolidation phase.
Considering the reversal of a 3.5-year downtrend in the Russell 2000 vs. S&P 500 ratio, Jasper expects the trend of small-cap outperformance to continue for months. With new risk-off signals emerging, potential pullback zones Jasper would look for include 5100-5191 on the S&P 500 and $443-$449 on the QQQ, expecting a low near the election. Investors can find more details on this research report by visiting Smartkarma and searching for analyst Joe Jasper‘s insights on UnitedHealth Group.
A look at UnitedHealth Group Incorporated Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to Smartkarma Smart Scores, UnitedHealth Group has a positive long-term outlook. With a high score in Dividend and Momentum, the company is seen as a stable investment with potential for growth. This indicates that UnitedHealth Group is likely to continue providing strong returns to its investors in the future.
UnitedHealth Group Incorporated, a company that owns and manages organized health systems, has received favorable scores in Value, Dividend, Growth, Resilience, and Momentum. This suggests that the company is well-positioned to weather market fluctuations and maintain its performance over the long term. With a focus on providing employers with products and resources for employee benefit programs, UnitedHealth Group serves customers globally and is poised for continued success.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
